Top 4 NASDAQ Stocks In The Diagnostic Substances Industry With The Highest ROI

Below are the top diagnostic substances stocks on the NASDAQ in terms of return on investment.

The trailing-twelve-month return on investment at Nymox Pharmaceutical Corporation (NASDAQ: NYMX) is 73.80%. Nymox Pharmaceutical's revenue for the same period is $3.20 million.

The trailing-twelve-month return on investment at Meridian Bioscience, Inc. (NASDAQ: VIVO) is 21.70%. Meridian Bioscience's EPS for the same period is $0.83.

The trailing-twelve-month return on investment at IDEXX Laboratories, Inc. (NASDAQ: IDXX) is 20.20%. IDEXX Laboratories' profit margin for the same period is 13.40%.

The trailing-twelve-month return on investment at SurModics, Inc. (NASDAQ: SRDX) is 11.20%. SurModics' PEG ratio is 1.66.